Topics
-
The “Three Cs” of C(D)MO Selection
Plus, what does it take for contract organizations to fall in the “Goldilocks” zone for pharmaceutical companies?Valdas Jurkauskas, Ph.D., Akebia Therapeutics 07.15.20
-
Biologics, Proteins, Vaccines | Parenterals
A Changing Healthcare Landscape
Navigating the road ahead with a focus towards patient centricityPeter Soelkner, Vetter Pharma International GmbH 01.28.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
GHO Capital Acquires Ardena
CDMO provides early stage drug development and manufacturing for small-to-mid sized biopharma.01.15.20
-
Bio News | Breaking News | Industry News | Information Technology
BrevisRefero Launches Online RFP Management Platform
Designed to connect biotech innovator companies with a global network of service providers.01.10.20
-
Managing Partnerships: Sponsors & CDMOs
How to earn – and keep – your spot atop corporations’ short lists of CDMOs.Judy Meyers, Sr. Business Development Manager, Grand River Aseptic Manufacturing 11.20.19
-
Breaking News | Industry News
Colorcon Launches $50M Venture Capital Fund
Pharmaceutical leader partners with Touchdown Ventures to fund promising startups09.18.19
-
Changing the Face of CDMOs
Looking for tomorrow’s biopharma leaders today.Le Ly and Peter Gallagher, Egon Zehnder 09.16.19
-
Biologics, Proteins, Vaccines | Biosimilars
Are Biotech Companies Strong Investments?
Biotech capital raised via IPO has increased dramatically over the past couple of years.Jason Monteleone , CEO, Clinipace 05.07.19
-
Biologics, Proteins, Vaccines
The Coming Revolution of Personalized Medicine
Cell and gene therapy is creating a momentous shift in the pharma landscape and reshaping the future of medicine.Tommy Fanning, Global Head Biopharmaceuticals, IDA Ireland 05.07.19
-
The Modern CDMO
Flexibility, collaboration and innovation are hallmark traits of today’s successful contract service organizations.Paul Quigley, Head of Drug Substance, Arcinova 05.07.19
-
R&D
-
Breaking News | Collaborations & Alliances | Industry News
Alvogen Investment Bolsters Asian Presence
Enters cross-investment partnership with Fuji to enhance market access to fast-growing Asian pharma market03.21.19
-
2019 Contract Manufacturing Industry Survey
We polled our readers to gain insight about their impressions of working with contract manufacturers.03.06.19
-
2019 Trends & Predictions
Looking to the year ahead we discuss six key trends that will shape the industry.David Hukin and Thomas Underwood, QVigilance and Quanticate 03.06.19
-
Biologics, Proteins, Vaccines
Preparing For Your CDMO Selection Process
Five questions that must be answered before starting your CDMO search.Ajinomoto Bio-Pharma Services 03.06.19
-
CDMO Market Trends
Vivek Sharma, CEO, Piramal Pharma Solutions, discusses outsourcing trends, opportunities, and the capabilities needed for today’s (bio)pharma pipelines.Kristin Brooks, Managing Editor, Contract Pharma 03.06.19
-
Breaking News | Industry News
Hovione Set for Production Capacity Expansion
CDMO issues $50 million bond to fuel growth plans01.30.19
-
Stock Perfomance for Top Pharma & Biopharma
Major acquisitions impact share prices in 2018Infographics
-
Dedicated to Excellence
Cambrex’s Shawn Cavanagh talks operational excellence and what it means to the CDMO.Tim Wright, Editor, Contract Pharma 11.13.18
-
Playing BIG
What does it take to acquire products from global pharma companies?Dr. Christoph Bieri, Managing Partner, Kurmann Partners AG 11.13.18
